Vermont healthcare organization OneCare Vermont is being closely watched because it was within 1% of meeting its financial target in its first year; scientists are turning to drug repurposing to methodically build upon previous research to find new drug candidates while saving time and expense; 2 organizations are investigating why so many American mothers die or nearly die in childbirth.
OneCare Vermont, a Vermont healthcare organization working to keep patients healthier while reducing costs, is being closely watched because it was within 1% of meeting its financial target in its first year and has now been expanded to cover about 18% of the state's population, the Associated Press reported. Officials said that last year it covered about 24,000 Medicaid patients and now covers about 112,000 patients whose healthcare is provided through Medicare, Medicaid, and commercial insurance. The long-term goal is to cover 70% of healthcare services by using specialized care to more closely manage chronic conditions like diabetes.
Instead of finding out that a drug developed for 1 purpose can also be used for another purely by accident, scientists are turning to drug repurposing to methodically build upon previous research to find new drug candidates while saving time and expense, the Washington Post reported. These may include drugs that were already been approved to treat a different disease, as well as drugs that were proven safe in clinical trials but were shelved before getting FDA approval.
NPR and ProPublica have been investigating why American mothers die in childbirth at a far higher rate than in all other developed countries and found a medical system that bases care on the idea that it's rare for a woman to die in childbirth. The organizations also found a system in which funding and resources are dedicated mostly to saving babies. A mother giving birth here is about 3 times as likely to die as a mother in Britain and Canada, and for every American woman who dies from childbirth, 70 nearly die. That adds up to more than 50,000 women who suffer "severe maternal morbidity" from childbirth each year, according to the CDC. A patient safety group, the Alliance for Innovation on Maternal Health, came up with an even higher figure of about 80,000.
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More